Get the Stockscreener App
5.87
4.08%
0.23
Novabay Pharmaceuticals Inc stock is traded at $5.87, with a volume of 452.47K.
It is up +4.08% in the last 24 hours and up +475.49% over the past month.
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
See More
Previous Close:
$5.64
Open:
$5.55
24h Volume:
452.47K
Relative Volume:
0.47
Market Cap:
$739.68M
Revenue:
$4.75M
Net Income/Loss:
$-7.83M
P/E Ratio:
26.96
EPS:
0.2177
Net Cash Flow:
$-7.24M
1W Performance:
+21.03%
1M Performance:
+475.49%
6M Performance:
+839.05%
1Y Performance:
+839.20%
1-Day Range:
$5.47
$6.299
1-Week Range:
$4.31
$6.50
52-Week Range:
$0.46
$6.50
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Name
Novabay Pharmaceuticals Inc
Sector
Industry
Phone
510-899-8800
Address
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
5.87 | 710.70M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-19 | Initiated | Ladenburg Thalmann | Buy |
| Jul-06-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Reiterated | Laidlaw | Buy |
| Jun-05-17 | Initiated | ROTH Capital | Buy |
| Mar-27-17 | Initiated | Laidlaw | Buy |
| Feb-06-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-07-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-14-15 | Reiterated | Maxim Group | Buy |
| Apr-30-15 | Resumed | Maxim Group | Buy |
| Mar-06-13 | Initiated | Ascendiant Capital Markets | Strong Buy |
| Jan-03-08 | Initiated | Dawson James | Speculative Buy |
View All
Novabay Pharmaceuticals Inc Stock (NBY) Latest News
What's Driving the Market Sentiment Around NovaBay Pharmaceuticals Inc? - Benzinga
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Hits New 1-Year High – Should You Buy? - Defense World
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Hits New 1-Year HighShould You Buy? - MarketBeat
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Gap DownWhat's Next? - MarketBeat
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Down 6.8%Should You Sell? - MarketBeat
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Trading 5.9% Higher – Still a Buy? - Defense World
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - MarketBeat
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Up 5.9%Still a Buy? - MarketBeat
Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Sahm
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Reaches New 1-Year High – Still a Buy? - Defense World
Is NovaBay Pharmaceuticals Inc. stock attractive for ETFs2025 Year in Review & Verified Momentum Stock Ideas - Улправда
NBY Stock Jumps Amid Market Anticipation and Economic Data Uncertainty - StocksToTrade
Vision Marine Technologies Soars as Wall Street Awaits Economic Indicators - timothysykes.com
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Hits New 12-Month HighTime to Buy? - MarketBeat
NovaBay Pharmaceuticals Shows Significant Pre-Market Movement Amid Market Stirrings - StocksToTrade
Can NovaBay Pharmaceuticals Inc. stock deliver double digit returnsWeekly Earnings Recap & Reliable Price Breakout Alerts - Улправда
How NovaBay Pharmaceuticals Inc. stock benefits from strong dollarJuly 2025 EndofMonth & Free Community Consensus Stock Picks - Улправда
Why retail traders accumulate NovaBay Pharmaceuticals Inc. (B9P0) stock2025 Major Catalysts & Technical Pattern Recognition Alerts - Улправда
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Gap UpTime to Buy? - MarketBeat
Will NovaBay Pharmaceuticals Inc. stock outperform tech sector in 2025July 2025 Analyst Calls & Verified Technical Trade Signals - Улправда
Can NovaBay Pharmaceuticals Inc. stock deliver surprise earnings beat2025 Pullback Review & Accurate Buy Signal Alerts - Bölüm Sonu Canavarı
Will NovaBay Pharmaceuticals Inc. stock deliver shareholder value2025 Geopolitical Influence & Verified Technical Trade Signals - DonanımHaber
Can NovaBay Pharmaceuticals Inc. stock attract analyst upgradesQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - DonanımHaber
Is NovaBay Pharmaceuticals Inc. stock a safe buy before earningsJuly 2025 Retail & Weekly Hot Stock Watchlists - Улправда
How NovaBay Pharmaceuticals Inc. stock valuations compare to rivalsWeekly Profit Recap & Technical Pattern Based Signals - DonanımHaber
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Trading Up 17.7%Time to Buy? - MarketBeat
Is NovaBay Pharmaceuticals Inc a good long term investmentVolatility Adjusted Trading & Capital Allocation Recommendations - earlytimes.in
NovaBay Pharmaceuticals Earnings Notes - Trefis
What analysts say about NovaBay Pharmaceuticals Inc stockStock Price Divergence & Free Grow Wealth With Picks - earlytimes.in
Will Banas Finance Limited Benefit From Sector TailwindsMarket Timing Techniques & Free Rapid Portfolio Appreciation - earlytimes.in
Why Did KALA BIO Shares Jump Over 22% After Hours? - Sahm
Is Novabay Pharmaceuticals Inc (NBY) positioned for future growth? - Setenews
Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionInsider Selling & Weekly Top Gainers Trade List - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat growth indexesQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
Is NovaBay Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Proven Capital Preservation Tips - Newser
Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosFed Meeting & Fast Gain Stock Trading Tips - Newser
Will NovaBay Pharmaceuticals Inc. stock recover faster than industryPortfolio Gains Summary & Safe Entry Momentum Stock Tips - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock split2025 Dividend Review & Safe Capital Investment Plans - Newser
Can NovaBay Pharmaceuticals Inc. stock double in coming years2025 Price Momentum & Growth Oriented Trade Recommendations - Newser
[S-8] NovaBay Pharmaceuticals, Inc. Employee Benefit Plan Registration | NBY SEC FilingForm S-8 - Stock Titan
What Sparked KALA BIO's Nearly 38% Surge Overnight? - Benzinga
[S-3/A] NovaBay Pharmaceuticals, Inc. Amended Shelf Registration Statement | NBY SEC FilingForm S-3/A - Stock Titan
NovaBay Pharmaceuticals Inc. (NBY) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
How NovaBay Pharmaceuticals Inc. stock trades under stagflationJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat revenue estimatesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Will NovaBay Pharmaceuticals Inc. stock deliver compounding returns2025 Stock Rankings & Weekly Setup with ROI Potential - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock rise with strong economyWeekly Trade Summary & Safe Entry Momentum Tips - newser.com
How NovaBay Pharmaceuticals Inc. (B9P0) stock performs during market turbulence - newser.com
Novabay Pharmaceuticals Inc Stock (NBY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):